PAX8 and nonpapillary renal cell carcinoma: Both PAX8 and HIF2α play an important role in E11:69419 transcriptional activity, and genetic inactivation of PAX8 is tolerated in the mouse kidney leading to the assumption that PAX8 synergistically to HIF2α could be a therapeutic target in ccRCC [69].